Both in Biotechnology
enGene Therapeutics vs Anavex Life Sciences
Over the past year ENGN returned −73.7% and AVXL returned −83.1%; their daily moves had a correlation of 0.14.
ENGN −73.7% AVXL −83.1%Growth of $1, one year, split-adjusted
| Metric | ENGN | AVXL |
|---|---|---|
| Price | $1.72 | $1.26 |
| Market cap | $115.3M | $116.8M |
| Today | +6.17% | +5.00% |
| 1 month | −4.4% | −21.3% |
| 6 months | −80.6% | −62.3% |
| Year to date | −81.0% | −64.6% |
| 1 year | −75.1% | −83.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $241.0M | $118.3M |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | 74.4% |
| Short % of float | 3.4% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).